联合应用彩超、钼靶、MRI对早期乳腺癌的诊断价值

 目的 探讨联合应用彩超、钼靶、MRI对早期乳腺癌的诊断价值。方法 回顾性分析2018-01至2019-10医院收治的118例术前完善了彩超、钼靶、MRI检测的早期乳腺癌可疑患者的临床资料,以术后病理诊断为金标准,比较彩超、钼靶、MRI与三者联合检测的灵敏度、特异度和准确率。结果 118例患者中,术前检测可疑为乳腺癌:彩超87例,钼靶88例,MRI 92例,三者联合检测103例;术前检测乳腺良性病变:彩超31例,钼靶33例,MRI26例,三者联合检测15例;术后病理诊断乳腺癌106例,乳腺良性病变12例。灵敏度分别为:彩超79.25％,钼靶80.19％,MRI 84.91％,三者联合97.17％;特异度分别为:彩超75.00％,钼靶75.00％,MRI 83.33％,三者联合100.00％;准确率分别为:彩超78.81％,钼靶79.66％,MRI 84.75％,三者联合97.46％。在灵敏度、特异度和准确率方面,彩超、钼靶、MRI三者联合检测高于各单项检测,差异有统计学意义(P<0.05)。结论 联合应用彩超、钼靶、MRI检测早期乳腺癌,在灵敏度、特异度和准确率方面有较大提升。

Clinical Study on Combined Application of Color Doppler Ultrasound,Molybdenum Target and MRI in Detection of Early Breast Cancer

Objective To study the combined detection value of color Doppler ultrasound, molybdenum target and MRI for early breast cancer. Methods From January 2018 to October 2019, 118 patients with suspected early breast cancer who had been detected by color Doppler ultrasound, molybdenum target and MRI before operation were retrospectively analyzed. In terms of sensitivity, specificity and accuracy, the postoperative pathological diagnosis was taken as the gold standard, and the differences of color Doppler ultrasound, molybdenum target, MRI and their combined detection were compared. Results Among 118 patients, breast cancer was suspected to be detected preoperatively: color Doppler ultrasound in 87 cases, molybdenum target in 88 cases, MRI in 92 cases, and 103 cases were detected by combination of the three. Preoperative detection of benign breast lesions: color Doppler ultrasound in 31 cases, molybdenum target in 33 cases, MRI26 in 26 cases, combined detection of the three in 15 cases; Postoperative pathology diagnosed 106 cases of breast cancer and 12 cases of benign breast lesions. The sensitivity of color Doppler ultrasound, molybdenum target, MRI and their combined detection are 79.25%, 80.19%, 84.91% and 97.17% respectively. The specificity was 75.00% for color Doppler ultrasound, 75.00% for molybdenum target, 83.33% for MRI, and 100.00% for combination of the three. The accuracy rates were 78.81% for color Doppler ultrasound, 79.66% for molybdenum target, 84.75% for MRI, and 97.46% for combination of the three. In terms of sensitivity, specificity and accuracy, the combined detection of color Doppler ultrasound, molybdenum target and MRI is higher than each single detection, with statistically significant difference (P<0.05). Conclusions Combined application of color Doppler ultrasound, molybdenum target and MRI to detect early breast cancer has greatly improved sensitivity, specificity and accuracy, and its clinical value is worthy of promotion.